Cost-effectiveness of roflumilast as an ad-on to bronchodilator and to combination of bronchodilator with anti-inflammatory therapies in patients with severe and very severe COPD and a history of exacerbations in Switzerland - Samyshkin, Y; Radford, M; Schlunegger, M P; Gooss, A (2011)
Poster No. PRS39